Sign inJoin waitlistJoin the waitlist

Kristina Deligiannidis

Director, Women’s Behavioral Health, Zucker Hillside Hospital, Northwell Health · New York Presbyterian Hospital

Credentials: · · ·

History

Reproductive Psychiatry · New York Presbyterian Hospital
Present
Zucker School of Medicine at Hofstra/Northwell
Present
Zucker School of Medicine at Hofstra/Northwell
Present

Psychiatry
2006–2010

Research

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
The Lancet · 2018 · 455 citations
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
The Lancet · 2017 · 335 citations
Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium
The Lancet Psychiatry · 2017 · 227 citations

Samantha Meltzer-Brody
10 papers
Anthony Rothschild
8 papers
SC
Sara Carlini
8 papers · 7 as a resident
David Rubinow
6 papers
Neill Epperson
6 papers
MF
Marlene Freeman
5 papers
RL
Robert Lasser
5 papers
SK
Stephen Kanes
5 papers
Jennifer Payne
4 papers
Constance Guille
3 papers
NB
Nancy Byatt
3 papers
RR
Robert Riesenberg
3 papers

Grants

Relationships Between Neuroactive Steroids, GABA and Glutamate MRS and Connectivity of the Default Mode Network in Postpartum Depression
National Institute of Mental Health · R01
Contact PI · $2.7M · Feinstein Institute for Medical Research
2020–2026
Neuroendocrine and Neuroimaging Endophenotypes in Postpartum Depression
National Institute of Mental Health · K23
Contact PI · $896.9K · Feinstein Institute for Medical Research
2013–2018

Clinical trials

Personalized Integrated Chronotherapy for Perinatal Depression
Principal investigator · Completed
Rhode Island Hospital
2020–2025
Memantine Augmentation of Antidepressants
Principal investigator · Completed · Phase 4
University of Massachusetts, Worcester
2006–2011